JPMorgan believes the $45 billion worth of investments and capex across business verticals to be fully value accretive by FY25. This is not priced in by the current stock price which offers an attractive risk-reward, the brokerage said.
Astonea Labs IPO allotment: Here’s how to check status, listing details and what GMP signals
Astonea Labs’ IPO allotment is expected to be finalized today, with shares potentially credited to successful bidders by June 2 and listing on June 3.
May 30, 2025